Delivery Order SPE2DB24D6044-SPE2DB25FLHXU

Award Date 5/2/25
Potential Completion Date 5/5/25
Potential Value $2.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This $1,270.65 firm fixed-price delivery order contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4566477281 METHYLERGONOVINE 0.2 MG/ML VLML, with a completion date of November 19, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of methylergonovine 0.2 mg tablets over a period ending in August 2024, with a ceiling value of $1,121.97. The contract was awarded as a delivery order, with a firm fixed price. There is no set-aside designation associated with this award. AmerisourceBergen holds several Indefinite Delivery Contracts...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4565735670 - Methylergonovine 0.2 mg/mL vials. The $2,970.20 firm-fixed-price contract has a completion date of September 10, 2024. While this delivery order is not designated as a set-aside, AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025,...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,596.71, is for the delivery of Methylergonovine 0.2 mg tablets. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of...
This federal contract award is between the Defense Logistics Agency (DLA) and Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,358.52, is for the delivery of methylergonovine 0.2 mg tablets to support military and government healthcare needs. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,498.80 firm fixed-price delivery order is for the supply of 4,567,972,776 units of the medication methylergonovine 0.2 mg tablet in 20-count units. The contract has an ultimate completion date of April 21, 2025 and was awarded on April 19, 2025. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery...
This is a $3,655.04 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,566,451,243 units of the drug methylergonovine 0.2 mg/ml in 1 ml vials. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of methylergonovine 0.2 mg/ml vials, a medication used to treat postpartum hemorrhage. The contract has a ceiling value of $1,261.51 and runs through March 13, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,209.24 firm fixed-price contract is for the supply of methylergonovine 0.2 mg/ml ampompoules, a prescription medication. No set-aside designation was used for this award. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, to...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The $1,794.96 contract is for the delivery of the drug methylergonovine 0.2 mg/ml to support military treatment programs and facilities. The contract has a completion date of February 27, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract with DLA, valued at up to...
  • SPE2DB24D6044
    Indefinite Delivery Contract
  • SPE2DB24D6044-SPE2DB25FLHXU
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,410.20, is for the delivery of 4568112775 methylergonovine 0.2 mg tablets. The contract has a period of performance through May 5, 2025 and is a firm fixed-price contract.

AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. This delivery order is likely one of multiple orders placed under that larger IDC contract, enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.

The contract is not designated as a set-aside and was therefore competed on an unrestricted basis.

Generated 8/3/25, 1:02 AM